Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

300.03 -14.15 (-4.50%)
Streaming Delayed Price Updated: 12:46 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 629,890
Open 310.54
Bid (Size) 299.88 (1)
Ask (Size) 300.50 (4)
Prev. Close 314.18
Today's Range 296.47 - 313.54
52wk Range 173.00 - 329.33
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process. 
Via Investor's Business Daily
Tesla, Progress Software, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga

Performance

YTD
+16.8%
+16.8%
1 Month
-7.7%
-7.7%
3 Month
+14.2%
+14.2%
6 Month
+13.9%
+13.9%
1 Year
+53.0%
+53.0%

More News

Read More
These S&P500 stocks are moving in today's pre-market session
Via Chartmill
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Via Benzinga
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
Via The Motley Fool
Topics Artificial Intelligence
INSULET CORP (NASDAQ:PODD) – A Strong Growth Stock with Technical Breakout Potential
Via Chartmill
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
From Insulet Corporation
Via Business Wire
Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
Via FinancialNewsMedia
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
From FN Media Group LLC
Via GlobeNewswire
1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of
Via StockStory
Tuesday's session: gap up and gap down stock in the S&P500 index
Via Chartmill
Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
From Insulet Corporation
Via Business Wire
PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption
Via StockStory
Topics Economy World Trade
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
3 Medical Technology Stocks Outperforming in 2025
Via MarketBeat
What's going on in today's session: S&P500 movers
Via Chartmill
Friday's session: top gainers and losers in the S&P500 index
Via Chartmill
3 Reasons Investors Love Insulet (PODD)
Via StockStory
Topics Stocks
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks
Via StockStory
Topics Artificial Intelligence
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
Via Benzinga
INSULET CORP (NASDAQ:PODD) – A Strong Growth Stock with Technical Breakout Potential
Via Chartmill
1 Surging Stock with Exciting Potential and 2 to Question
Via StockStory
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From Insulet Corporation
Via Business Wire

Frequently Asked Questions

Is Insulet Corporation - Common Stock publicly traded?
Yes, Insulet Corporation - Common Stock is publicly traded.
What exchange does Insulet Corporation - Common Stock trade on?
Insulet Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insulet Corporation - Common Stock?
The ticker symbol for Insulet Corporation - Common Stock is PODD on the Nasdaq Stock Market
What is the current price of Insulet Corporation - Common Stock?
The current price of Insulet Corporation - Common Stock is 300.03
When was Insulet Corporation - Common Stock last traded?
The last trade of Insulet Corporation - Common Stock was at 07/01/25 12:46 PM ET
What is the market capitalization of Insulet Corporation - Common Stock?
The market capitalization of Insulet Corporation - Common Stock is 20.66B
How many shares of Insulet Corporation - Common Stock are outstanding?
Insulet Corporation - Common Stock has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.